ARM 2022: Industry Briefs on Cell and Gene Therapies
One global network, the Alliance for Regenerative Medicine (ARM), represents 400 members from industry and academia in advocating for innovations and support of cell, gene, tissue-based advanced therapies.
At the ARM’s virtual 2022 Cell & Gene State of the Industry Briefing, two experts highlighted the sector’s progress in 2021 and welcomed industry experts to share their views on the promising future of regenerative medicine in 2022 and 2023. The speakers are:
It's free! Log in now to read
LATEST
NUS Researchers Use Evolutionary Biology Models to Map Singapore Shophouse Architectural Development
2026-08-11
City St George’s Launches €6 Million REMADE Project to Advance Circular Renovation in Urban Neighborhoods
2026-08-10
Digital Science Releases Two Model Context Protocol Servers for Dimensions Research Platform
2026-08-10
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia




